StoryNote
Log in
|
Sign up
/u/High_Sleep3694's
posts in
/r/biotech_stocks
Year:
All
2024
Show search filters
Search by title:
Hide posts already read
Only show posts with narrations
FDA Greenlights Adaptimmune’s (NASDAQ: ADAP) Gene Therapy for Rare Soft Tissue Cancer
3 upvotes
Mark as read:
--
10
9
8
7
6
5
4
3
2
1
0
Add to a list
Novo Nordisk (NYSE: NVO) Misses Q2 Profit Estimates, Updates 2024 Sales and Profit Outlooks
1 upvotes
Mark as read:
--
10
9
8
7
6
5
4
3
2
1
0
Add to a list
Title
Upvotes
Mark as read
Favorited
Rating
Add to a list
FDA Greenlights Adaptimmune’s (NASDAQ: ADAP) Gene Therapy for Rare Soft Tissue Cancer
3
--
10
9
8
7
6
5
4
3
2
1
0
Novo Nordisk (NYSE: NVO) Misses Q2 Profit Estimates, Updates 2024 Sales and Profit Outlooks
1
--
10
9
8
7
6
5
4
3
2
1
0
«
<
>
»
Page
of 1
Go
StoryNote